As TrialSite has monitored allergic vaccine reactions associated with mRNA-based COVID-19 vaccines under U.S. Food and Drug Administration (FDA) emergency […]
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical […]
On Thursday Johnson & Johnson filed for an EUA with the FDA after reporting compelling preliminary results from its large […]
Australia’s drug regulator, the Therapeutic Goods Administration (TGA), granted a provisional approval to Pfizer Australia Pty Ltd for its COVID-19 […]
Bayer, Germany’s largest pharmaceutical company, inked a deal with CureVac in a bid to accelerate a new class of transformative medicines […]
In response to the COVID-19 pandemic, biotech firms have embraced the use of mRNA (messenger ribonucleic acid) technology, disrupting vaccine […]
The University of Iowa Health Care (UIHC) gains a more prominent role as a trial site hub investigating COVID-19 investigational […]
Germany’s CureVac N.V. (Nasdaq: CVAC) a globally focused biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic […]
As larger groups of people get vaccinated with the Pfizer/BioNTech vaccine for COVID-19, the U.S. Food and Drug Administration (FDA) […]
In a well publicized event, Northwell Health, New York State’s largest provider of hospitals, health centers and clinics made history […]
